These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34097294)

  • 1. Lessons for the clinical nephrologist: recurrent pregnancy-associated thrombotic microangiopathy (TMA) with a known complement mutation and features of preeclampsia; a diagnostic and therapeutic dilemma.
    Smith P; Abdelmaguid A; Clark K; Bramham K
    J Nephrol; 2021 Oct; 34(5):1673-1676. PubMed ID: 34097294
    [No Abstract]   [Full Text] [Related]  

  • 2. A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
    Che M; Moran SM; Smith RJ; Ren KYM; Smith GN; Shamseddin MK; Avila-Casado C; Garland JS
    Kidney Int; 2024 May; 105(5):960-970. PubMed ID: 38408703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome.
    Sperati CJ; Moliterno AR
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):541-59. PubMed ID: 26043391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
    Kistler AD
    Praxis (Bern 1994); 2016 Mar; 105(7):389-96. PubMed ID: 27005733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic microangiopathy during pregnancy.
    Zununi Vahed S; Rahbar Saadat Y; Ardalan M
    Microvasc Res; 2021 Nov; 138():104226. PubMed ID: 34252400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.
    Fakhouri F; Scully M; Provôt F; Blasco M; Coppo P; Noris M; Paizis K; Kavanagh D; Pène F; Quezada S; Hertig A; Kissling S; O'Brien P; Delmas Y; Alberio L; Winer N; Veyradier A; Cataland S; Frémeaux-Bacchi V; Loirat C; Remuzzi G; Tsatsaris V
    Blood; 2020 Nov; 136(19):2103-2117. PubMed ID: 32808006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset and relapsed thrombotic microangiopathy post-COVID-19 vaccination.
    Ma Q; Xu G
    J Med Virol; 2023 Jul; 95(7):e28946. PubMed ID: 37436788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis.
    Fakhouri F; Scully M; Ardissino G; Al-Dakkak I; Miller B; Rondeau E
    J Nephrol; 2021 Oct; 34(5):1581-1590. PubMed ID: 33826112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
    Huerta A; Arjona E; Portoles J; Lopez-Sanchez P; Rabasco C; Espinosa M; Cavero T; Blasco M; Cao M; Manrique J; Cabello-Chavez V; Suñer M; Heras M; Fulladosa X; Belmar L; Sempere A; Peralta C; Castillo L; Arnau A; Praga M; Rodriguez de Cordoba S
    Kidney Int; 2018 Feb; 93(2):450-459. PubMed ID: 28911789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.
    Gaggl M; Aigner C; Csuka D; Szilágyi Á; Prohászka Z; Kain R; Haninger N; Knechtelsdorfer M; Sunder-Plassmann R; Sunder-Plassmann G; Schmidt A
    J Am Soc Nephrol; 2018 Mar; 29(3):1020-1029. PubMed ID: 29282226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.
    Saleem M; Shaikh S; Hu Z; Pozzi N; Java A
    Front Immunol; 2022; 13():909503. PubMed ID: 35720299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.
    Lee H; Kang E; Kang HG; Kim YH; Kim JS; Kim HJ; Moon KC; Ban TH; Oh SW; Jo SK; Cho H; Choi BS; Hong J; Cheong HI; Oh D
    Korean J Intern Med; 2020 Jan; 35(1):25-40. PubMed ID: 31935318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How we manage thrombotic microangiopathies in pregnancy.
    Thomas MR; Robinson S; Scully MA
    Br J Haematol; 2016 Jun; 173(6):821-30. PubMed ID: 27019232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse of atypical hemolytic uremic syndrome triggered by COVID-19: a lesson for the clinical nephrologist.
    Uwatoko R; Shindo M; Hashimoto N; Iio R; Ueda Y; Tatematsu Y; Kato N; Maruyama S; Hayashi T
    J Nephrol; 2023 Jun; 36(5):1439-1442. PubMed ID: 36877369
    [No Abstract]   [Full Text] [Related]  

  • 17. Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase.
    Sakurai S; Kato H; Yoshida Y; Sugawara Y; Fujisawa M; Yasumoto A; Matsumoto M; Fujimura Y; Yatomi Y; Nangaku M
    J Atheroscler Thromb; 2020 Apr; 27(4):353-362. PubMed ID: 31484852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic-therapeutic algorithm for thrombotic microangiopathy. A report of two cases.
    Rubio-Haro R; Quesada-Carrascosa M; Hernández-Laforet J; Ferrer Gómez C; De Andrés J
    Rev Esp Anestesiol Reanim (Engl Ed); 2022 Mar; 69(3):179-182. PubMed ID: 35283062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathies of pregnancy: Differential diagnosis.
    Gupta M; Feinberg BB; Burwick RM
    Pregnancy Hypertens; 2018 Apr; 12():29-34. PubMed ID: 29674195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab.
    Cammett TJ; Garlo K; Millman EE; Rice K; Toste CM; Faas SJ
    Mol Diagn Ther; 2023 Jan; 27(1):61-74. PubMed ID: 36329366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.